[go: up one dir, main page]

EA200500074A1 - Пленочное покрытие для таблеток и каплет - Google Patents

Пленочное покрытие для таблеток и каплет

Info

Publication number
EA200500074A1
EA200500074A1 EA200500074A EA200500074A EA200500074A1 EA 200500074 A1 EA200500074 A1 EA 200500074A1 EA 200500074 A EA200500074 A EA 200500074A EA 200500074 A EA200500074 A EA 200500074A EA 200500074 A1 EA200500074 A1 EA 200500074A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tablets
gunlets
film coating
dosage forms
coating compositions
Prior art date
Application number
EA200500074A
Other languages
English (en)
Other versions
EA007619B1 (ru
Inventor
Доминик Николя Каде
Эварт Томас Коле
Фредерик Жан Жозеф Хен
Роберт Энтони Скотт
Original Assignee
УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си filed Critical УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си
Publication of EA200500074A1 publication Critical patent/EA200500074A1/ru
Publication of EA007619B1 publication Critical patent/EA007619B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Wrappers (AREA)

Abstract

Настоящее изобретение относится к новым композициям для нанесения покрытия для применения на твердые лекарственные формы, такие как таблетки или каплеты, к твердым лекарственным формам, покрытым данной композицией, и к способам приготовления указанных композиций для нанесения покрытия.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200500074A 2002-08-09 2003-07-30 Пленочное покрытие для таблеток и каплет EA007619B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02292020A EP1396263A1 (en) 2002-08-09 2002-08-09 Film coating for tablets and caplets
PCT/IB2003/003442 WO2004014344A1 (en) 2002-08-09 2003-07-30 Film coating for tablets and caplets

Publications (2)

Publication Number Publication Date
EA200500074A1 true EA200500074A1 (ru) 2005-08-25
EA007619B1 EA007619B1 (ru) 2006-12-29

Family

ID=31502831

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500074A EA007619B1 (ru) 2002-08-09 2003-07-30 Пленочное покрытие для таблеток и каплет

Country Status (16)

Country Link
US (3) US7914820B2 (ru)
EP (2) EP1396263A1 (ru)
JP (2) JP4652052B2 (ru)
CN (1) CN100500137C (ru)
AT (1) ATE497760T1 (ru)
AU (1) AU2003249464C1 (ru)
BR (1) BR0313220A (ru)
CA (1) CA2494045C (ru)
DE (1) DE60335991D1 (ru)
EA (1) EA007619B1 (ru)
ES (1) ES2357949T3 (ru)
MX (1) MXPA05001605A (ru)
NZ (1) NZ537750A (ru)
PT (1) PT1539114E (ru)
SI (1) SI1539114T1 (ru)
WO (1) WO2004014344A1 (ru)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
US20100086591A1 (en) 2006-09-15 2010-04-08 Murachanian Dennis C Rapidly Disintegrating Dosage Form
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
US9649278B2 (en) * 2011-10-12 2017-05-16 Dow Global Technologies Llc Injection-molded dosage form
US20150343075A1 (en) * 2014-06-02 2015-12-03 Aimmune Therapeutics Placebo formulations and uses thereof
US9744221B2 (en) 2014-12-23 2017-08-29 Synthetic Biologics, Inc. Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
EP3664823B1 (en) 2017-08-07 2024-06-05 Finch Therapeutics Holdings LLC Composition for use in preventing or treating an enterococcal blood stream infection
US11338020B2 (en) 2018-01-09 2022-05-24 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
JP2021514968A (ja) 2018-02-23 2021-06-17 フィンチ セラピューティクス ホールディングス エルエルシー 微生物関連の免疫療法
US11654184B2 (en) 2018-03-20 2023-05-23 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
CA3094173A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Intestinal alkaline phosphatase formulations
CN109535496A (zh) * 2018-11-13 2019-03-29 黄冈师范学院 一种可降解的透水性包衣膜的制备方法
ES3024384T3 (en) 2019-07-18 2025-06-04 Theriva Biologics Inc Intestinal alkaline phosphatase-based treatments of metabolic disorders
WO2021016081A1 (en) 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
WO2021050965A1 (en) 2019-09-13 2021-03-18 Crestovo Holdings Llc Compositions and methods for treating autism spectrum disorder
CN115279382A (zh) 2019-10-18 2022-11-01 芬奇治疗控股有限责任公司 用于向受试者递送细菌代谢物的组合物和方法
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
TW202140049A (zh) 2020-01-10 2021-11-01 美商芬奇治療控股有限責任公司 用於治療ｂ型肝炎（ｈｂｖ）及ｄ型肝炎（ｈｄｖ）之組合物及方法
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
US20230201265A1 (en) 2020-03-31 2023-06-29 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
US20240263251A1 (en) 2021-02-19 2024-08-08 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA753851B (en) * 1974-08-01 1976-05-26 Ici Ltd Film coating process
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
GB2256648B (en) * 1991-05-29 1995-08-30 Colorcon Ltd Wax polish composition
JPH05144624A (ja) 1991-11-21 1993-06-11 Mitsubishi Steel Mfg Co Ltd 磁気記録媒体およびその製造方法
AU674840B2 (en) * 1992-01-17 1997-01-16 Bpsi Holdings, Inc. Film coatings and film coating compositions based on cellulosic polymers and lactose
TW237386B (ru) * 1992-04-15 1995-01-01 Ciba Geigy
JPH06157325A (ja) * 1992-11-30 1994-06-03 Mitsubishi Kasei Corp 経口コレステロール低下剤
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
JP3670016B2 (ja) * 1994-12-16 2005-07-13 ワーナー−ランバート・カンパニー カプレットをカプセル内に封入する方法及びかかる方法により得ることができる固体剤形
US6245350B1 (en) * 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
BR9810027A (pt) * 1997-06-11 2000-09-12 Procter & Gamble Comprimido revestido por pelìcula para melhorada segurança do trato gastrintestinal superior
JP3677156B2 (ja) * 1997-09-05 2005-07-27 武田薬品工業株式会社 医薬
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
DE10033023A1 (de) * 2000-07-07 2002-01-31 Biogrund Gmbh Filmüberzugszusammensetzung auf Basis von Zellulosederivaten und Zuckeralkoholen
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
JP3885484B2 (ja) * 2000-11-07 2007-02-21 カシオ計算機株式会社 データ通信処理装置及び記録媒体
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
JP5144624B2 (ja) 2009-10-28 2013-02-13 京セラドキュメントソリューションズ株式会社 画像形成装置

Also Published As

Publication number Publication date
AU2003249464B2 (en) 2008-09-25
EP1396263A1 (en) 2004-03-10
CN100500137C (zh) 2009-06-17
US8557294B2 (en) 2013-10-15
ATE497760T1 (de) 2011-02-15
EP1539114B1 (en) 2011-02-09
CA2494045A1 (en) 2004-02-19
EA007619B1 (ru) 2006-12-29
US7914820B2 (en) 2011-03-29
CA2494045C (en) 2010-01-05
MXPA05001605A (es) 2005-04-25
JP2005539019A (ja) 2005-12-22
BR0313220A (pt) 2005-06-14
AU2003249464C1 (en) 2009-03-05
CN1674876A (zh) 2005-09-28
SI1539114T1 (sl) 2011-05-31
AU2003249464A1 (en) 2004-02-25
US20050249810A1 (en) 2005-11-10
JP2011026337A (ja) 2011-02-10
US20140105975A1 (en) 2014-04-17
JP4652052B2 (ja) 2011-03-16
PT1539114E (pt) 2011-03-24
WO2004014344A1 (en) 2004-02-19
US20110142925A1 (en) 2011-06-16
DE60335991D1 (de) 2011-03-24
NZ537750A (en) 2007-09-28
EP1539114A1 (en) 2005-06-15
ES2357949T3 (es) 2011-05-04

Similar Documents

Publication Publication Date Title
EA200500074A1 (ru) Пленочное покрытие для таблеток и каплет
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
EA200800240A1 (ru) Производные тиазола в качестве активатора амфк
ATE433447T1 (de) Pyrimiidinverbindungen
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
DE60314623D1 (de) Substituierte pyrazolopyrimidine
BR0212968A (pt) Composição farmacêutica, composto, e, método para tratar ou prevenir condições mediadas pelo ccr2, mcp-1 ou pela interação destes
BRPI0412659A (pt) isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto
ECSP067110A (es) Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica
SE0301700D0 (sv) Novel compounds
NO20071901L (no) Substituerte bisykliske imidazo-3-ylamin sammensetninger
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
EA200602196A1 (ru) Производные пиразола, композиции, содержащие эти соединения, и способы применения
UA86413C2 (ru) Сахарное покрытие и твердая дозированая форма, которая его содержит
NO20043367L (no) Oralt farmasoytisk preparat
NO20062824L (no) 1,3-Difenylprop-2-en-1-on-avledete forbindelser, fremgangsmater for fremstilling derav, samt anvendelse av samme
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
BRPI0417157A (pt) composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
NO20054787D0 (no) Indenderivater som farmasotiske midler
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
DK1730147T3 (da) Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser til behandling af fedme

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU